This white paper will examine the use of sputum induction as a pharmacodynamic method to optimize respiratory patient clinical trials, including comparison to other methods, and a case study looking at asthma patients and healthy volunteers.
Business Assurance
Tenancy A, Level 5, Building 3, Central Park,
660 Great South Road, Ellerslie,
Auckland, New Zealand